Product
EU103
Name
EU103
1 clinical trial
1 indication
Indication
Solid TumorClinical trial
A Dose-escalation, Single-arm, Open-Label, Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in an Advanced or Metastatic Solid Tumors Who Have Failed Standard TherapyStatus: Recruiting, Estimated PCD: 2025-04-30